Company: DTCK
Filing Date: 2025-03-24
Form Type: F-3
Source: 0001683168-25-001820
Chunk: 10

Company: DAVIS COMMODITIES Ltd
Filing Date: 2025-03-24
Form: F-3
Chunk 10
---
 for service of process in the United States is Cogency Global Inc., located at 122 East 42nd Street, 18th Floor, New York, NY 10168.

| 6 |

<div align='center'>RISK FACTORS</div>

Investing in our securities involves a high degree
of risk. You should carefully consider the risk factors set forth under “Risk Factors” described in our most recent annual
report on Form 20-F, filed on May 15, 2024, as supplemented and updated by subsequent current reports on Form 6-K that we have filed with
the SEC, together with all other information contained or incorporated by reference in this prospectus and any applicable prospectus supplement
and in any related free writing prospectus in connection with a specific offering, before making an investment decision. Each of the risk
factors could materially and adversely affect our business, operating results, financial condition and prospects, as well as the value
of an investment in our securities, and the occurrence of any of these risks might cause you to lose all or part of your investment.

<div align='center'>OFFER STATISTICS AND EXPECTED TIMETABLE</div>

We may from time to time, offer and sell any combination
of the securities described in this prospectus up to a total dollar amount of $30,000,000 in one or more offerings. The securities offered
under this prospectus may be offered separately, together, or in separate series, and in amounts, at prices, and on terms to be determined
at the time of sale. We will keep the registration statement of which this prospectus is a part effective until such time as all of the
securities covered by this prospectus have been disposed of pursuant to and in accordance with such registration statement.

<div align='center'>USE OF PROCEEDS</div>

Except as described in any prospectus supplement
and any free writing prospectus in connection with a specific offering, we currently intend to use the net proceeds from the sale of the
securities offered under this prospectus for general corporate purposes. We may also use a portion of the net proceeds to acquire or invest
in technologies, products and/or businesses that we believe will enhance the value of our Company, although we have no current commitments
or agreements with respect to any such transactions as of the date of this prospectus. We have not determined the amount of net proceeds
to be used specifically for the foregoing purposes. As a result, our management will have